Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04221204 · ClinicalTrials.gov registry record · Phase 1

A Monotherapy in Subjects With Advanced Solid Tumors

A Phase 1 study of Solid Tumor, Adult, sponsored by 3D Medicines (Beijing) Co..

Active
Registry status
Phase 1
Development phase
42
Enrollment target
2
Study locations

NCT04221204 is a Phase 1 study of Solid Tumor, Adult that is active but no longer recruiting, run by 3D Medicines (Beijing) Co.. The registered enrollment target is 42 participants, below the 190-participant average among 72 other Solid Tumor, Adult trials with a reported enrollment target (78% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04221204, a Phase 1 study of Solid Tumor, Adult, is active but no longer recruiting, sponsored by 3D Medicines (Beijing) Co..

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
42 participants
Enrollment target
2
Study locations

Study Summary

A Phase 1 Study of the Safety, Tolerability, Pharmacokinetics Profiles, and Preliminary Efficacy of 3D185 Monotherapy in Subjects with Advanced Solid Tumors

Conditions Studied

Solid Tumor, Adult

Interventions

  • DRUG Highly selective FGFR1-3 inhibitor

Study Locations (2)

California

  • Sarcoma Oncolog Research Center - Santa Monica

Other

  • Shanghai East Hospital - Shanghai

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2019-09-01
Est. Completion 2026-12-30
Phase Phase 1

Sponsor

3D Medicines (Beijing) Co.

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04221204

The ClinicalTrials.gov registry entry for NCT04221204 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 190-participant average among 72 other Solid Tumor, Adult trials with a reported enrollment target (78% lower). The listed sponsor is 3D Medicines (Beijing) Co., which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Solid Tumor, Adult appearing as the primary indexed condition, and to 1 intervention - of which Highly selective FGFR1-3 inhibitor is the first listed.

NCT04221204 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Other.

Frequently Asked Questions

What is clinical trial NCT04221204 about?

NCT04221204 is a clinical study titled "A Monotherapy in Subjects With Advanced Solid Tumors". A Phase 1 Study of the Safety, Tolerability, Pharmacokinetics Profiles, and Preliminary Efficacy of 3D185 Monotherapy in Subjects with Advanced Solid Tumors

What is the current status of trial NCT04221204?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 42 participants. The study started on 2019-09-01. Estimated completion is 2026-12-30.

What conditions does trial NCT04221204 study?

This clinical trial studies the following conditions: Solid Tumor, Adult.

What interventions are being tested in trial NCT04221204?

The interventions under investigation include: Highly selective FGFR1-3 inhibitor (DRUG).

Who is sponsoring clinical trial NCT04221204?

This trial is sponsored by 3D Medicines (Beijing) Co., which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04221204 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Solid Tumor, Adult

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Solid Tumor, Adult

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.